ASM International NV (LON:0NX3)
509.40
-7.60 (-1.47%)
At close: Dec 19, 2025
ASM International NV Revenue
ASM International NV had revenue of 800.00M EUR in the quarter ending September 30, 2025, with 2.75% growth. This brings the company's revenue in the last twelve months to 3.28B, up 19.13% year-over-year. In the year 2024, ASM International NV had annual revenue of 2.93B with 11.33% growth.
Revenue (ttm)
3.28B EUR
Revenue Growth
+19.13%
P/S Ratio
7.61
Revenue / Employee
720.45K EUR
Employees
4,558
Market Cap
21.81B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.93B | 298.39M | 11.33% |
| Dec 31, 2023 | 2.63B | 223.40M | 9.27% |
| Dec 31, 2022 | 2.41B | 681.02M | 39.37% |
| Dec 31, 2021 | 1.73B | 401.79M | 30.25% |
| Dec 31, 2020 | 1.33B | 44.26M | 3.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |